ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)
Clinical trial NCT02546934 · COMPLETED
Trial details
- NCT number
- NCT02546934
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-04-01
- Enrollment
- 254
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.